Showing results (471-480 of 657) with videos related to

Sort By:
Pageof 66
Autoimmunity Reviews|August 4, 2009
Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registryFrancesca Bobbio Pallavicini, Roberto Caporali, Piercarlo Sarzi-Puttini, et al.
Clinical Reviews in Allergy & Immunology|June 24, 2009
Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational studyMatteo Filippini, Chiara Bazzani, Ennio Giulio Favalli, et al.
Biomed Research International|May 8, 2014
Prevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational studyDelia Colombo, Sergio Chimenti, Paolo Grossi, et al.
Clinical and Experimental Rheumatology|February 25, 2011
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanerceptEnnio Lubrano, Antonio Spadaro, Antonio Marchesoni, et al.
Gynecologic and Obstetric Investigation|April 19, 2002
Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsiaAngela V D'Elia, Lorenza Driul, Roberta Giacomello, et al.
Current Developments in Nutrition|November 21, 2022
Maternal Mediterranean Diet Adherence and Its Associations with Maternal Prenatal Stressors and Child GrowthSarah Gonzalez-Nahm, Joddy Marchesoni, Arnab Maity, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1986
Localized ovarian cancer: surgery plus chemotherapyM V Fiorentino, O Nicoletto, P de Besi, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
Circulation Research|September 16, 2000
Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cellsH Lee, W Shi, P Tontonoz, et al.
Clinical and Experimental Rheumatology|September 13, 2011
Recommendations for the use of biologic therapy in the treatment of psoriatic arthritis: update from the Italian Society for RheumatologyCarlo Salvarani, Nicolò Pipitone, Antonio Marchesoni, et al.
Pageof 66